Compared with small molecule and protein therapeutics, peptides have several attractive features, such as high structural compatibility with target proteins, the ability to disrupt the protein-protein interface, and small size. The efficient design of high-affinity peptide through reasonable methods has become a major obstacle to the
development of this potential drug class.